Baudendistel I, Noest S, Peters-Klimm F, Herzberg H, Scherer M, Blozik E, Joos S (2015) Bridging the gap between patient needs and quality indicators: a qualitative study with chronic heart failure patients. Patient Prefer Adherence 30:1397–1405
Nakhjiri LZ, Darvishpour A, Pourghane P, Chaboki BG (2021) The relationship between frailty syndrome and self-care ability in the elderly with heart failure. J Educ Health Promot 10(1)
Angermann CE, Gelbrich G, Störk S, Gunold H, Edelmann F, Wachter R et al (2016) Effect of escitalopram on all-cause mortality and hospitalization in patients with heart failure and depression: the MOOD-HF randomized clinical trial. JAMA 315(24):2683–2693
Article CAS PubMed Google Scholar
Moradi M, Doostkami M, Behnamfar N, Rafiemanesh H, Behzadmehr R (2022) Global prevalence of depression among heart failure patients: a systematic review and meta-analysis. Curr Probl Cardiol 47(6):100848
Piepenburg SM, Faller H, Gelbrich G, Störk S, Warrings B, Ertl G et al (2015) Comparative potential of the 2-item versus the 9-item patient health questionnaire to predict death or rehospitalization in heart failure. Circ Heart Failure 8(3):464–72
Rutledge T, Reis VA, Linke SE, Greenberg BH, Mills PJ (2006) Depression in heart failure: a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol 48(8):1527–1537
Ruo B, Rumsfeld JS, Hlatky MA, Liu H, Browner WS, Whooley MA (2003) Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA 290(2):215–221
Article PubMed PubMed Central Google Scholar
Moraska AR, Chamberlain AM, Shah ND, Vickers KS, Rummans TA, Dunlay SM et al (2013) Depression, healthcare utilization, and death in heart failure a community study. Circ Heart Failure 6(3):387–94
Article CAS PubMed Google Scholar
Gehi A, Musselman D, Otte C, Royster EB, Ali S, Whooley MA (2010) Depression and platelet activation in outpatients with stable coronary heart disease: findings from the Heart and Soul Study. Psychiatry Res 175(3):200–204
Article CAS PubMed Google Scholar
Podolecki T, Pudlo R, Mazurek M, Koziel M, Jedrzejczyk-Patej E, Boidol J et al (2017) The incidence, clinical significance, and treatment effects of depression in cardiac resynchronization therapy recipients. Cardiology 138(2):115–121
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg 88:105906
Freedland KE, Carney RM, Rich MW, Steinmeyer BC, Rubin EH (2015) Cognitive behavior therapy for depression and self-care in heart failure patients: a randomized clinical trial. JAMA Intern Med 175(11):1773–1782
Article PubMed PubMed Central Google Scholar
Jolly K, Taylor R, Lip GY, Greenfield S, Raftery J, Mant J et al (2007) The Birmingham Rehabilitation Uptake Maximisation Study (BRUM). Home-based compared with hospital-based cardiac rehabilitation in a multi-ethnic population: cost-effectiveness and patient adherence. Health Technol Assess (Winchester, England) 11(35):1–118
Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan—a web and mobile app for systematic reviews. Syst Rev 5:1–10
Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savović J, Schulz KF, Weeks L, Sterne JA (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343
van Valkenhoef G, Lu G, de Brock B, Hillege H, Ades A, Welton NJ (2012) Automating network meta-analysis. Research synthesis methods 3(4):285–299
Béliveau A, Boyne DJ, Slater J, Brenner D, Arora P (2019) BUGSnet: an R package to facilitate the conduct and reporting of Bayesian network meta-analyses. BMC Med Res Methodol 19(1):1–13
Yeong T, Mai AS, Lim OZ, Ng CH, Chin YH, Tay P et al (2022) Can glucose-lowering medications improve outcomes in non-diabetic heart failure patients? A Bayesian network meta-analysis. ESC Heart Failure 9(2):1338–1350
Article PubMed PubMed Central Google Scholar
Sterne JA, Egger M, Smith GD (2001) Investigating and dealing with publication and other biases in meta-analysis. BMJ 323(7304):101–105
Article CAS PubMed PubMed Central Google Scholar
Wickham H, Averick M, Bryan J, Chang W, McGowan LDA, François R et al (2019) Welcome to the Tidyverse. Journal of open source software 4(43):1686
Balduzzi S, Rücker G, Schwarzer G (2019) How to perform a meta-analysis with R: a practical tutorial. BMJ Ment Health 22(4):153–160
Balduzzi S, Rücker G, Nikolakopoulou A, Papakonstantinou T, Salanti G, Efthimiou O et al (2023) netmeta: an R package for network meta-analysis using frequentist methods. J Stat Softw 106:1–40
Kutcher SA, Flatman L, Haber R, Dendukuri N, Dandona S, Brophy J (2023) The efficacy and safety of the prasugrel, ticagrelor, and clopidogrel dual antiplatelet therapies following an acute coronary syndrome: A systematic review and Bayesian network meta-analysis. medRxiv 2023–08
Plummer M, Stukalov A, Denwood M. (2016) rjags: Bayesian graphical models using MCMC. R package version. 4(6)
Lett HS, Blumenthal JA, Babyak MA, Sherwood A, Strauman T, Robins C et al (2004) Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosom Med 66(3):305–315
Tu RH, Zeng ZY, Zhong GQ, Wu WF, Lu YJ, Bo ZD et al (2014) Effects of exercise training on depression in patients with heart failure: a systematic review and meta-analysis of randomized controlled trials. Eur J Heart Fail 16(7):749–757
Ski CF, Jelinek M, Jackson AC, Murphy BM, Thompson DR (2016) Psychosocial interventions for patients with coronary heart disease and depression: a systematic review and meta-analysis. Eur J Cardiovasc Nurs 15(5):305–316
Hosseini SH, Ghaemian A, Mehdizadeh E, Ashraf H (2014) Contribution of depression and anxiety to impaired quality of life in survivors of myocardial infarction. Int J Psychiatry Clin Pract 18(3):175–181
Hosseini SH, Ghaemian A, Mehdizadeh E, Ashraf H (2014) Levels of anxiety and depression as predictors of mortality following myocardial infarction: a 5-year follow-up. Cardiol J 21(4):370–377
Hosseini SH, Yousefnejad K, Tabiban S, Nesarhoseyni V, Bagheri B, Kiasari AM et al (2011) Effects of depression and anxiety symptoms on cardiac mortality following myocardial infarction: a 2-year follow-up. Int J Psychiatry Clin Pract 15(2):91–96
Jeyanantham K, Kotecha D, Thanki D, Dekker R, Lane DA (2017) Effects of cognitive behavioural therapy for depression in heart failure patients: a systematic review and meta-analysis. Heart Fail Rev 22(6):731–741
Article PubMed PubMed Central Google Scholar
Mhanna M, Sauer MC, Al-Abdouh A, Jabri A, Abusnina W, Safi M, Beran A, Mansour S (2023) Cognitive behavioral therapy for depression in patients with heart failure: a systematic review and metanalysis of randomized control trials. Heart Fail Rev 28(5):1091–100
Dekker RL (2008) Cognitive behavioral therapy for depression in patients with heart failure: a critical review. Nurs Clin North Am 43(1):155–170
Balata M, Gbreel MI, Elrashedy AA, Westenfeld R, Pfister R, Zimmer S et al (2023) Clinical effects of cognitive behavioral therapy in heart failure patients: a meta-analysis of randomized controlled trials. BMC Complementary Medicine and Therapies 23(1):280
Article PubMed PubMed Central Google Scholar
He W, Zhou Y, Ma J, Wei B, Fu Y (2020) Effect of antidepressants on death in patients with heart failure: a systematic review and meta-analysis. Heart Fail Rev 25:919–926
Article CAS PubMed Google Scholar
Tousoulis D, Antoniades C, Drolias A, Stefanadi E, Marinou K, Vasiliadou C et al (2008) Selective serotonin reuptake inhibitors modify the effect of β-blockers on long-term survival of patients with end-stage heart failure and major depression. J Cardiac Fail 14(6):456–464
Brouwers C, Christensen SB, Damen NL, Denollet J, Torp-Pedersen C, Gislason GH et al (2016) Antidepressant use and risk for mortality in 121,252 heart failure patients with or without a diagnosis of clinical depression. Int J Cardiol 203:867–873
Fosb lEL, Gislason GH, Poulsen HE, Hansen ML, Folke F, Schramm TK et al (2009) Prognosis in heart failure and the value of β-blockers are altered by the use of antidepressants and depend on the type of antidepressants used. Circ Heart Fail 2(6):582–90
Hedrick R, Korouri S, Tadros E, Darwish T, Cortez V, Triay D, Pasini M, Olanisa L, Herrera N, Hanna S, Kimchi A (2020) The impact of antidepressants on depressive symptom severity, quality of life, morbidity, and mortality in heart failure: a systematic review. Drugs Context 9
Sokoreli I, De Vries J, Pauws S, Steyerberg E (2016) Depression and anxiety as predictors of mortality among heart failure patients: systematic review and meta-analysis. Heart Fail Rev 21:49–63
Article CAS PubMed Google Scholar
Rustad JK, Stern TA, Hebert KA, Musselman DL (2013) Diagnosis and treatment of depression in patients with congestive heart failure: a review of the literature. The primary care companion for CNS disorders 15(4):26254
Taylor RS, Long L, Mordi IR, Madsen MT, Davies EJ, Dalal H et al (2019) Exercise-based rehabilitation for heart failure Cochrane systematic review, meta-analysis, and trial sequential analysis. JACC Heart Fail 7(8):691–705
Sagar VA, Davies EJ, Briscoe S, Coats AJ, Dalal HM, Lough F et al (2015) Exercise-based rehabilitation for heart failure: systematic review and meta-analysis. Open heart 2(1):e000163
Article PubMed PubMed Central Google Scholar
Piepoli M (2013) Exercise training in chronic heart failure: mechanisms and therapies. Neth Hear J 21(2):85–90
Comments (0)